Associations Between Genetic Variation in the Targets of Low-Density Lipoprotein-Lowering Drugs and Rheumatoid Arthritis

Circ Genom Precis Med. 2024 Feb;17(1):e004232. doi: 10.1161/CIRCGEN.123.004232. Epub 2023 Dec 4.

Authors

Chenxi Qin¹, Sara Hägg¹

Affiliation

¹ Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

PMID: 38047393
DOI: 10.1161/CIRCGEN.123.004232

No abstract available

Keywords: Mendelian randomization analysis; apolipoproteins B; arthritis, rheumatoid; genetic variation; inflammation.

MeSH terms

Arthritis, Rheumatoid* / drug therapy
Arthritis, Rheumatoid* / genetics
Genetic Variation
Humans
Lipoproteins, LDL*
Risk Factors

Substances

Lipoproteins, LDL